Skip to main content
Equibles

Dieter Weinand

Board Member

Replimune Group, Inc. (REPL)

Chairman

Replimune Group, Inc. (REPL)

Board Member

Coya Therapeutics, Inc. (COYA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Dieter Weinand

Dieter Weinand is recorded as Board Member and Chairman at Replimune Group, Inc. (REPL) and Board Member at Coya Therapeutics, Inc. (COYA). Replimune Group, Inc. reported in an 8-K filed March 26, 2024 that Dieter Weinand was appointed lead independent director of the Board, effective April 1, 2024. Coya Therapeutics, Inc. reported in an 8-K filed August 21, 2023 that Dieter Weinand was appointed Class I director, effective August 18, 2023.

“Dieter Weinand, the Company's current chair of the Board, will transition into the newly created role of the lead independent director of the Board”
Replimune Group, Inc. Form 8-K, filed March 26, 2024 · Read the filing
“On August 18, 2023, the board of directors (the “Board”) of Coya Therapeutics, Inc. (the “Company”) increased the size of the Board to six directors from five, and appointed Dieter Weinand as a Class I director to fill the newly created vacancy.”
Coya Therapeutics, Inc. Form 8-K, filed August 21, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Coya Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Replimune Group, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.